CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 17 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,845,000 | +60.0% | 105,101 | +2.5% | 0.00% | 0.0% |
| Q4 2017 | $1,153,000 | -32.1% | 102,516 | -35.7% | 0.00% | -33.3% |
| Q3 2017 | $1,698,000 | +2.8% | 159,436 | -15.5% | 0.00% | 0.0% |
| Q2 2017 | $1,652,000 | +313.0% | 188,777 | +456.4% | 0.00% | +200.0% |
| Q1 2017 | $400,000 | -33.4% | 33,928 | -26.0% | 0.00% | 0.0% |
| Q4 2016 | $601,000 | +112.4% | 45,858 | +410.4% | 0.00% | 0.0% |
| Q1 2015 | $283,000 | – | 8,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|